Phase Ib/II Trial to Evaluate Safety and Efficacy of Oral Ixazomib in Combination With Sirolimus and Tacrolimus in the Prophylaxis of Chronic Graft-versus-host Disease.
Phase of Trial: Phase I/II
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Ixazomib (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary)
- Indications Graft-versus-host disease; Transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 21 Mar 2017 New trial record